Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
Clinical trial NCT01110889 · COMPLETED
Trial details
- NCT number
- NCT01110889
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-07-01
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.